Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 422.39% vs 0.00% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is -84.62% vs -53.57% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 23.50% vs -22.19% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 24.55% vs 5.12% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 11.12% vs 10.05% in Mar 2024
Compare Balance Sheet Results of Anuh Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
25.06
4.70
20.36
433.19%
Share Warrants & Outstandings
Total Reserve
300.97
115.20
185.77
161.26%
Shareholder's Funds
326.02
121.47
204.55
168.40%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
12.80
-12.80
-100.00%
Secured Loans
0.00
12.80
-12.80
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-2.08
4.14
-6.22
-150.24%
Other Long Term Liabilities
0.06
0.00
0.06
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
2.03
2.37
-0.34
-14.35%
Total Non-Current Liabilities
0.01
19.30
-19.29
-99.95%
Current Liabilities
Trade Payables
156.84
62.95
93.89
149.15%
Other Current Liabilities
11.00
11.17
-0.17
-1.52%
Short Term Borrowings
10.50
92.71
-82.21
-88.67%
Short Term Provisions
0.17
0.00
0.17
0.00%
Total Current Liabilities
178.51
166.83
11.68
7.00%
Total Liabilities
504.55
307.60
196.95
64.03%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
111.06
62.98
48.08
76.34%
Less: Accumulated Depreciation
61.36
16.40
44.96
274.15%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
49.70
46.57
3.13
6.72%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.27
0.00
0.27
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
51.95
0.00
51.95
0.00%
Long Term Loans & Advances
2.64
3.36
-0.72
-21.43%
Other Non Current Assets
15.30
0.46
14.84
3,226.09%
Total Non-Current Assets
128.38
50.40
77.98
154.72%
Current Assets Loans & Advances
Current Investments
53.86
0.81
53.05
6,549.38%
Inventories
74.48
175.00
-100.52
-57.44%
Sundry Debtors
215.87
64.85
151.02
232.88%
Cash and Bank
19.74
1.35
18.39
1,362.22%
Other Current Assets
11.48
1.44
10.04
697.22%
Short Term Loans and Advances
0.75
13.76
-13.01
-94.55%
Total Current Assets
376.17
257.20
118.97
46.26%
Net Current Assets (Including Current Investments)
197.66
90.37
107.29
118.72%
Total Current Assets Excluding Current Investments
322.31
256.39
65.92
25.71%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
504.55
307.60
196.95
64.03%
Contingent Liabilities
25.26
0.00
25.26
0.00%
Total Debt
10.50
105.51
-95.01
-90.05%
Book Value per share (adjusted)
32.53
255.15
-222.62
-87.25%
Annual - Borrowings
Borrowings 10.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 422.39% vs 0.00% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.06 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -84.62% vs -53.57% in Mar 2024
Annual - Fixed Assets
Fixed Assets 49.97 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 23.50% vs -22.19% in Mar 2024
Annual - Investments
Investments 51.95 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 24.55% vs 5.12% in Mar 2024
Annual - Current Assets
Current Assets 376.17 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.12% vs 10.05% in Mar 2024






